Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System

Exclusion Criteria

• •Significant coagulopathy that cannot be adequately corrected.
• •Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment.
• •Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
• •Subjects who are uncooperative or cannot follow instructions.
• •Mental state that may preclude completion of the study procedure.
• •Pregnant or nursing female subjects.